يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Abadía, Mario"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
  4. 4
    رسالة جامعية

    المساهمون: Garcia Mora, Mauricio

    جغرافية الموضوع: Medicina

    وصف الملف: pdf; application/pdf

    العلاقة: 1. Hall B, Padussis J, Foster JM. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastasis. Vol. 97, Surgical Clinics of North America. 2017. p. 671–82.; 2.Jin K, Gao W, Lu Y, Lan H, Teng L, Cao F. Mechanisms regulating colorectal cancer cell metastasis into liver (review). Oncol Lett. 2012;3(1):11–5.; 3.Kusamura S, González-Moreno S, Nizri E, Baratti D, Guadagni S, Guaglio M, et al. Learning Curve, Training Program, and Monitorization of Surgical Performance of Peritoneal Surface Malignancies Centers. Surg Oncol Clin N Am. 2018 Jul;27(3):507–17.; 4. Chan DL, Morris DL, Rao A, Chua TC. Intraperitoneal chemotherapy in ovarian cancer: A review of tolerance and efficacy. Vol. 4, Cancer Management and Research. 2012. p. 413–22.; 5. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545–50.; 6.Koppe MJ, Boerman OC, Oyen WJG, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Vol. 243, Annals of Surgery. 2006. p. 212–22.; 7.Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358–63.; 8.Elias DM, Ouellet JF. Intraperitoneal chemohyperthermia: rationale, technique, indications, and results. Surg Oncol Clin N Am. 2001;10(4):915–33, xi.; 9.Lambert LA, Harris A. Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: Current clinical practice or misnomer? Vol. 7, Journal of Gastrointestinal Oncology. 2016. p. 112–21.; 11.Newton AD, Bartlett EK, Karakousis GC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A review of factors contributing to morbidity and mortality. Vol. 7, Journal of Gastrointestinal Oncology. 2016. p. 99–111.; 12.Kusamura S, Baratti D, Hutanu I, Rossi P, Deraco M. The Importance of the Learning Curve and Surveillance of Surgical Performance in Peritoneal Surface Malignancy Programs. Vol. 21, Surgical Oncology Clinics of North America. 2012. p. 559–76.; 13.Glehen O, Mithieux F, Osinsky D, Beaujard AC, Freyer G, Guertsch P, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol. 2003;21(5):799–806.; 14.Klaver YLB, Lemmens VEPP, Creemers GJ, Rutten HJT, Nienhuijs SW, de Hingh IHJT. Populationbased survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol. 2011;22(10):2250–6.; 15.Ozols RF. Treatment goals in ovarian cancer. Int J Gynecol Cancer. 2005;15(s1):3–11.; 16.Low RN, Barone RM, Lucero J. Comparison of MRI and CT for Predicting the Peritoneal Cancer Index (PCI) Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures. Ann Surg Oncol. 2015;22(5):1708–15.; 17.Gilly FN, Cotte E, Brigand C, Monneuse O, Beaujard AC, Freyer G, et al. Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol. 2006;32(6):597–601.; 18. Sprat JS, Adcock RA, Sherrill W, Travathen IS. Hyperthermic peritoneal perfusion system in canines. Cancer Res. 1980;40(2):253–5.; 19.Morano WF, Khalili M, Chi DS, Bowne WB, Esquivel J. Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions—A systematic review. J Surg Oncol. 2018;117(2):245–59.; 20.Neuwirth MG, Alexander HR, Karakousis GC. Then and now: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective. Vol. 7, Journal of Gastrointestinal Oncology. 2016. p. 18–28.; 21.Koga S. Prophylactic and therapeutic continuous hyperthermic peritoneal perfusion for peritoneal metastases of gastric cancer. Gan No Rinsho. 1985;31(9 Suppl):1103–5.; 22.Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221 29–42. 1995;221(1):29–42.; 23.Esquivel J. Cytoreductive Surgery for Peritoneal Malignancies-Development of Standards of Care for the Community. Vol. 16, Surgical Oncology Clinics of North America. 2007. p. 653–66.; 24.Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005;2:3.; http://hdl.handle.net/10654/35072Test

  5. 5
  6. 6
  7. 7
    دورية أكاديمية
  8. 8